Dr. Osipov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-423-6313
Education & Training
Virginia Commonwealth University School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2015 - 2027
MD State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma Start of enrollment: 2019 Jun 04
Roles: Contact
Publications & Presentations
PubMed
- ctDNA-guided adjuvant immunotherapy in colorectal cancer.Nicholas Burley, Yurhee Lee, Louisa Liu, Alexandra Gangi, Yosef Nasseri
Immunotherapy. 2024-11-17 - A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy.Murtaza Ahmed, Brent K Larson, Arsen Osipov, Nilofer Azad, Andrew Hendifar
Oncotarget. 2024-10-11 - 1 citationsAccuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma.Gerardo Perrotta, Ghada Mohamed, Brent K Larson, Arsen Osipov, Cristina R Ferrone
JAMA. 2024-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
